成都普瑞法科技开发有限公司欢迎您!
ISO ISO
CNAS CNAS
高新技术企业 高新技术企业
USP USP
知识产权管理体系认证证书 知识产权管理体系认证证书

文献列表

专业生产定制高含量植提产品和中药成分

您当前的位置:
期刊名:BIOMEDICAL REPORTS 2
文献编号:
文献地址: https://scholar.google.com/scholar_url?url=https://www.spandidos-publications.com/10.3892/br.2024.1773/download&hl=zh-CN&sa=X&d=6176156577524793344&ei=J-oRZsrnLO-_6rQPzc-GiAI&scisig=AFWwaebC9NlBLMc2WeJLtfqey0dy&oi=scholaralrt&hist=P1l9U8wAAAAJ:5602017072534772868:AFWwaeaNlribOCTJHjZC3KEvdiTK&html=&pos=2&folt=kw
发表日期:March 22, 2024
Stroke is an important medical problem in devel‑
oping countries, characterized by a sudden disruption of blood
supply to the brain, either through occlusion or hemorrhage.
It is a major cause of neurological impairment, resulting in
high medical costs. The present study examined the effect of
6‑gingerol on morphological changes, antioxidant defenses, and
the anti‑apoptotic factors p38 mitogen‑activated protein kinase
(MAPK) and mitofusin (Mfn)2, in a rat model of focal cerebral
ischemia. A total of 60 healthy male Wistar rats were randomly
allocated into six groups: Control, right middle cerebral artery
occlusion (Rt.MCAO) + vehicle, Rt.MCAO + piracetam, and
Rt.MCAO + 6‑Gin 5, 10 and 20 mg/kg BW groups. The results
indicated that 6‑gingerol treatment for a duration of 7 days
reverses morphological alterations, enhances catalase and
glutathione peroxidase activities, reduces Bax, caspase‑3 and
MAPK expression, and increases Bcl‑xL and Mfn2 expres‑
sion in the cortex and hippocampus. In conclusion, 6‑gingerol
demonstrated significant in vivo effectiveness in mitigating
pathological changes induced by cerebral ischemia. This
beneficial effect is attributed, at least in part, to preservation of
antioxidant defenses and activation of anti‑apoptotic pathways.
相关产品